The largest database of trusted experimental protocols

10 protocols using edta collection tube

1

Mouse Blood and Tissue Sampling

Check if the same lab product or an alternative is used in the 5 most similar protocols
PB sampling was performed via tail vein puncture. Prior to sampling, cages were placed in front of a heat lamp for several minutes, following which mice were then placed in a holding restraint. The tails were swabbed with ethanol and a small incision was made to the lateral tail vein using a GoldenRod lancet (MEDIpoint Inc). No more than 100 μL of PB was collected in EDTA-collection tubes (Becton-Dickinson) and stored at −20°C until DNA extraction. Pressure was applied to the wound until bleeding ceased prior to returning animals to their cages. At the final time-point, mice were euthanised by CO2 asphyxiation following blood sampling. Spleen and liver were isolated and embedded in cryoprotectant (OCT compound, Tissue-Tek), frozen on dry ice and stored at −80°C until subsequent DNA extraction.
+ Open protocol
+ Expand
2

Plasma Collection for Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood was obtained using EDTA collection tubes (Becton, Dickinson and Company, Franklin Lakes, NJ) and centrifuged at 2680 rpm at 4°C for 10 minutes. Aliquots of the resulting blood plasma were distributed into labeled cryovials and stored at −80°C until analysis.
+ Open protocol
+ Expand
3

Impella Reduces VWF Multimer Size

Check if the same lab product or an alternative is used in the 5 most similar protocols
Calves were implanted with an Impella®, which was expected to reduce the size of the VWF multimers, as has been observed in patients[19 (link),36 (link)]. Next, after 168 hours (7 days) of Impella® implantation, one bolus of PBS (volume based on the volume of the administered mAb 17C7) was injected and blood was sampled 2 (T2), 24 (T24), 48 (T48), 72 (T72) and 168 (T168) hours after PBS injection. As PBS injection was not expected to have an effect on VWF multimers, the same calf was treated with the inhibitory anti-ADAMTS13 mAb 17C7 since this allowed us to reduce the number of animals needed for this study. Subsequently, 168 hours after PBS injection, one bolus of 600 μg/kg of the inhibitory mAb 17C7 was given intravenously and blood was sampled, 2 (T2), 24 (T24), 48 (T48), 72 (T72) and 168 (T168) hours after mAb 17C7 injection (Figure 4A). Blood was collected on citrate, heparin and EDTA collection tubes (BD, New Jersey, US) right before Impella® implantation (BL) and at 2 (T2), 24 (T24), 48 (T48), 72 (T72) and 168 (T168) hours after Impella® implantation and PBS/mAb 17C7 injection (Figure 3A).
+ Open protocol
+ Expand
4

Venous Blood Sampling and Processing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were obtained in the morning by venipuncture of the median cubital vein after overnight fasting, using commercial ethylenediaminetetraacetic acid (EDTA) collection tubes (BD Medical, Franklin Lakes, NJ, USA). Samples were immediately centrifuged at 1000× g for 10 min at 4 °C, aliquots were prepared, and stored at −80 °C until analysis.
+ Open protocol
+ Expand
5

Peripheral Blood Mononuclear Cell Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood samples were obtained from volunteers by a licensed phlebotomist via venipuncture. Approximately 25 mL of blood per person was collected in EDTA collection tubes (BD Biosciences, Franklin Lakes, NJ) and labeled with a unique identifier. Heparinized blood was overlayed onto room temperature Ficoll (Sigma Aldrich, St. Louis, MO) in a 1:1 ratio in a sterile 50 mL conical tube. Samples were centrifuged at 400×g for 30 min at ambient lab temperature (~ 21 °C) with the brake off to ensure that deceleration did not disrupt the density gradient. Two milliliters of sera from each subject’s sample was stored at − 80 °C for subsequent antibody-reactivity testing. The buffy coat, containing the mononuclear cell layer, was extracted using a transfer pipette and washed three times with lipopolysaccharide (LPS)-free phosphate-buffered saline (PBS). Cells were resuspended in RPMI 1640 medium (Sigma, St Louis, MO) plus 10% human serum (50:50 male:female, Innovative Research, Novi, MI) and counted on a hemocytometer using a 1:1 Trypan blue (Sigma Aldrich, St. Louis, MO) exclusion (0.4% solution). Aliquots of 2 × 108 viable cells/2 mL were cryopreserved using a method described previously [29 (link)] and infected at a later date.
+ Open protocol
+ Expand
6

Plasma Separation and HIV-1 Viral Load Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
A whole blood sample (4.5 mL) was collected in EDTA collection tubes (BD, Franklin Lakes, NJ, USA). Plasma was obtained by centrifuging the collected whole blood sample at 956 × g for 15 min. Viral load testing was done at the respective study sites following the national guidelines for the management of HIV and AIDS,9 using the HIV-1 assay on the COBAS 6800/8800 platforms from Roche (Roche Diagnostics, Branchburg, NJ, USA), which employ the use of automatic RNA extraction using magnetic glass particle technology and purification followed by real-time PCR using TaqMan hydrolysis probes.22
+ Open protocol
+ Expand
7

EBOV Antibody Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum samples were collected by saphenous bleed in EDTA collection tubes (BD, Franklin Lakes, New Jersey) and aliquoted for storage at −80°C. Human IgG and murine IgG concentrations were quantified using commercially available kits (Abcam, Cambridge, United Kingdom, ab195215 and ab157719). Reciprocal antibody titers were determined by coating half-area 96-well plates (Corning, New York) with 1 μg/mL recombinant EBOV GP (IBT Bioservices, Rockville, DC, 0501-001), EBOV VP40 (IBT Bioservices, Rockville, DC, 0564-001), or Influenza A virus HA (SinoBiological Beijing, China, 11,684-V08H) protein overnight at 4°C. Plates were washed four times with 0.2% PBS-Tween20 (PBS-T) and blocked with SuperBlock buffer (Fisher, Waltham, Massachusetts). 2-fold serial dilutions were incubated at 37°C for 1 h and then washed four times with PBS-T. Secondary antibody (Pierce P31430) was incubated at 1:2,000 for 1 h at 37°C, washed four times with PBS-T, and incubated with TMB substrate (Pierce PI34021) for 15 min before reading absorbance values at 650 nm. Reciprocal titer was defined as the highest 2-fold serum dilution that gave an OD650 value 2-fold greater than negative control wells.
+ Open protocol
+ Expand
8

Isolating Activated Neutrophils from Hypertensive Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
After determining optimal timing for blood collection of in vivo LPS-activated neutrophils (n = 4), Dahl salt-sensitive hypertensive rats, genetically identical strain for hsICH rat model, (n = 2) were injected IV with 500µl LPS (Sigma Cat#L2630, 1.8 mg/kg in saline) 2hrs prior to blood collection. Five mLs of whole blood were collected in EDTA collection tube (BD Biosciences Cat#366450) under deep anesthesia, followed by euthanasia. The blood was brought to room temperature, layered onto a double gradient Histopaque (Sigma-Aldrich 10771 and 11191 respectively) as per manufacturer’s specifications (Millipore Sigma) and spun 800 x g for 30 minutes. Neutrophils were collected at the 1077/1191 interface, washed with 5 ml RPMI-1640 medium (Sigma Cat# R0883-500 ml) containing 1% BSA. In P96-well plates 50,000 live cells in 200 µL RPMI-1640 containing 1% BSA were incubated with 10a3 and 6g8 monoclonal antibodies (30 µg/ml) for 6 hours at 37°C and 5% CO2 respectively. Each condition was performed with 6 replicates. Live and dead cells were distinguished using trypan blue dye exclusion assay and counted in a phase contrast microscope.
+ Open protocol
+ Expand
9

Neutrophil Survival Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rats were injected intravenously with fresh LPS (Sigma Cat#L2630) 1.8 mg/kg in saline (final volume of 500 μl) 2 h prior to blood collection. Five mls of whole blood were collected in an EDTA collection tube (BD Biosciences Cat#366450) and diluted with 5 ml of Cell-based Assay Red Blood Cell lysis buffer (Cayman Cat#600611), mixed and layered over 3 ml of Histopaque (Sigma Cat#11191) in a 15 ml Falcon tube. The sample was spun 500 g for 30 min at RT. The yellow and clear top layer were discarded and the red pellet containing the RBCs and neutrophils were resuspended in 10 ml of Cell-based Assay Red Blood Cell lysis buffer (Cayman Cat#600611) and incubated for 10 min at RT to lyse the RBCs. Neutrophils were collected by centrifugation at 1200g × 10 min, washed with 5 ml RPMI-1640 medium (Sigma Cat# R0883) containing 1% BSA and resuspended in 2 ml RPMI-1640 containing 1% BSA. For the inhibition of survival assay, 50,000 live cells in 200 µl RPMI-1640 containing 1% BSA were seeded in P96 well plates. Each condition was performed in 4 replicates testing increasing concentrations of mAb (0.3–30 μg/ml). After 6 h at 37 °C, 5% CO2 incubation, live and dead cells were counted by using trypan blue vital stain.
+ Open protocol
+ Expand
10

Blood Sample Collection for CTC Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thirty-three patients were recruited in the study, however only 30 patients donated their blood samples, therefore their identification numbers are in the range P1 to P33. Three healthy volunteers were also included in the study. Each patient or healthy volunteer donated two blood samples in a 10 ml EDTA collection tube (BD, Franklin Lakes, NJ, USA). The blood samples were processed within 1 h after collection to ensure the highest viability of the CTCs. One tube was used for Parsortix® and the other for MACS® separation. After separation, cytological slides were prepared as described below.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!